cisapride has been researched along with Hyperplasia in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The serotonin4 (5-HT4) receptor agonists cisapride and/or metoclopramide have been shown to stimulate cortisol secretion in some patients with ACTH-independent bilateral macronodular adrenal hyperplasias (AIMAH) causing Cushing's syndrome." | 7.72 | Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. ( Bastard, C; Bertherat, J; Caron, P; Cartier, D; Kuhn, JM; Lacroix, A; Lefebvre, H; Lihrmann, I; Parmentier, F; Tabarin, A; Vaudry, H; Young, J, 2003) |
| "The serotonin4 (5-HT4) receptor agonists cisapride and/or metoclopramide have been shown to stimulate cortisol secretion in some patients with ACTH-independent bilateral macronodular adrenal hyperplasias (AIMAH) causing Cushing's syndrome." | 3.72 | Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. ( Bastard, C; Bertherat, J; Caron, P; Cartier, D; Kuhn, JM; Lacroix, A; Lefebvre, H; Lihrmann, I; Parmentier, F; Tabarin, A; Vaudry, H; Young, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feelders, RA | 1 |
| Lamberts, SW | 1 |
| Hofland, LJ | 1 |
| van Koetsveld, PM | 1 |
| Verhoef-Post, M | 1 |
| Themmen, AP | 1 |
| de Jong, FH | 1 |
| Bonjer, HJ | 1 |
| Clark, AJ | 1 |
| van der Lely, AJ | 1 |
| de Herder, WW | 1 |
| Cartier, D | 1 |
| Lihrmann, I | 1 |
| Parmentier, F | 1 |
| Bastard, C | 1 |
| Bertherat, J | 1 |
| Caron, P | 1 |
| Kuhn, JM | 1 |
| Lacroix, A | 1 |
| Tabarin, A | 1 |
| Young, J | 1 |
| Vaudry, H | 1 |
| Lefebvre, H | 1 |
| Mannelli, M | 1 |
| Ferruzzi, P | 1 |
| Luciani, P | 1 |
| Crescioli, C | 1 |
| Buci, L | 1 |
| Corona, G | 1 |
| Serio, M | 1 |
| Peri, A | 1 |
3 other studies available for cisapride and Hyperplasia
| Article | Year |
|---|---|
Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
Topics: Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Chorionic Gonadotr | 2003 |
Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Cisapride; Cushing | 2003 |
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Cisapride; Cushing Syndrome; Female; Gene Expression; H | 2003 |